Virbac SA (LON:0NM7)
342.50
+1.50 (0.44%)
At close: Jul 14, 2025
Virbac Revenue
In the year 2024, Virbac had annual revenue of 1.40B EUR with 12.07% growth. Virbac had revenue of 694.45M in the half year ending December 31, 2024, with 15.78% growth.
Revenue
1.40B EUR
Revenue Growth
+12.07%
P/S Ratio
2.14
Revenue / Employee
219.54K EUR
Employees
6,365
Market Cap
2.47B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.40B | 150.48M | 12.07% |
Dec 31, 2023 | 1.25B | 30.71M | 2.53% |
Dec 31, 2022 | 1.22B | 152.22M | 14.31% |
Dec 31, 2021 | 1.06B | 129.77M | 13.89% |
Dec 31, 2020 | 934.20M | -4.14M | -0.44% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |